Search bioRxiv⌕ Search

Biology subjects

Maor, G.

Publications and source records attributed to Maor, G..

2 recordsLinked to original sources

Biotin rescues manganese-induced Parkinson's disease phenotypes and neurotoxicity

Occupational exposure to manganese (Mn) induces manganism and has been widely linked as a contributing environmental factor to Parkinsons disease (PD), featuring dramatic signature overlaps between the two in motor symptoms and clinical hallmarks. However, the molecular mechanism underlying such link remains elusive, and for combating PD, effective mechanism-based therapies are lacking. Here, we developed an adult Drosophila model of Mn toxicity to recapitulate key parkinsonian features, spanning behavioral deficits, neuronal loss, and dysfunctions in lysosome and mitochondria. We performed global metabolomics on flies at an early stage of toxicity and identified metabolism of the B vitamin, biotin (vitamin B7), as a master pathway underpinning Mn toxicity with systemic, body-brain increases in Mn-treated groups compared to the controls. Using BtndRNAi mutant flies, we show that biotin depletion exacerbates Mn-induced neurotoxicity, parkinsonism, and mitochondrial dysfunction; while in Mn-exposed wild-type flies, biotin feeding dramatically ameliorates these pathophenotypes. We further show in human induced stem cells (iPSCs)- differentiated midbrain dopaminergic neurons that the supplemented biotin protects against Mn-induced neuronal loss, cytotoxicity, and mitochondrial dysregulation. Finally, human data profiling biotin-related proteins show for PD cases elevated circulating levels of biotin transporters but not of metabolic enzymes compared to healthy controls, suggesting humoral biotin transport as a key event involved in PD. Taken together, our findings identified compensatory biotin pathway as a convergent, systemic driver of Mn toxicity and parkinsonian pathology, providing new basis for devising effective countermeasures against manganism and PD. Significance StatementEnvironmental exposure to manganese (Mn) may increase the risk for Parkinsons disease (PD); however, the mechanistic basis linking the two remains unclear. Our adult fruit fly (Drosophila) model of Mn toxicity recapitulated key Parkinsons hallmarks in vivo spanning behavioral deficits, neuronal loss, and mitochondrial dysfunction. Metabolomics identified the biotin (vitamin B7) pathway as a key mediator, featuring systemic biotin increases in the flies. Rescue trials leveraging biotin-deficient flies, wild-type flies, and human iPSC-derived dopaminergic neurons determined biotin as a driver of manganism, with the parkinsonian phenotypes dramatically reversed through biotin supplementation. Our findings, in line with overexpressed circulating biotin transporters observed in PD patients, suggest compensatory biotin pathway as a key to untangle the Mn-PD link for combating neurodegenerative disease.

neuroscience↗

α-synuclein promotes neuronal dysfunction and death by disrupting the binding of ankyrin to β-spectrin

-synuclein plays a key role in the pathogenesis of Parkinsons disease and related disorders, but critical interacting partners and molecular mechanisms mediating neurotoxicity are incompletely understood. We show that -synuclein binds directly to {beta}-spectrin. Using males and females in a Drosophila model of -synuclein-related disorders we demonstrate that {beta}-spectrin is critical for -synuclein neurotoxicity. Further, the ankyrin binding domain of {beta}-spectrin is required for -synuclein binding and neurotoxicity. A key plasma membrane target of ankyrin, Na+/K+ ATPase, is mislocalized when human -synuclein is expressed in Drosophila. Accordingly, membrane potential is depolarized in -synuclein transgenic fly brains. We examine the same pathway in human neurons and find that Parkinsons disease patient-derived neurons with a triplication of the -synuclein locus show disruption of the spectrin cytoskeleton, mislocalization of ankyrin and Na+/K+ ATPase, and membrane potential depolarization. Our findings define a specific molecular mechanism by which elevated levels of -synuclein in Parkinsons disease and related -synucleinopathies leads to neuronal dysfunction and death. Significance StatementThe small synaptic vesicle associate protein -synuclein plays a critical role in the pathogenesis of Parkinsons disease and related disorders, but the disease-relevant binding partners of -synuclein and proximate pathways critical for neurotoxicity require further definition. We show that -synuclein binds directly to {beta}-spectrin, a key cytoskeletal protein required for localization of plasma membrane proteins and maintenance of neuronal viability. Binding of -synuclein to {beta}-spectrin alters the organization of the spectrin-ankyrin complex, which is critical for localization and function of integral membrane proteins, including Na+/K+ ATPase. These finding outline a previously undescribed mechanism of -synuclein neurotoxicity and thus suggest potential new therapeutic approaches in Parkinsons disease and related disorders.

neuroscience↗